Stay Updated with the Latest HSBC FTSE EPRA/NAREIT Developed UCITS ETF H4ZL.DE News in Real Time
Find H4ZL.DE news now at Meyka AI. Stay informed with the latest HSBC FTSE EPRA/NAREIT Developed UCITS ETF stocks updates, including price news, market analysis, and expert insights.
Crypto Prices Today: Bitcoin Near $62,557, ETH Below $1,800 After Nasdaq Rout
Crypto markets extended their decline on June 24 as investors reduced exposure to risk assets following a sharp selloff in technology stocks. Bitcoin traded near $62,557, while Ethereum remained below the key $1,800 level, reflecting broader weakness across digital assets. The latest drop came as the Nasdaq suffered one of its biggest declines in weeks,…
FTSE 100 Swings Higher by 0.09% as DAX Falls 0.65% on Tech Rout
European markets delivered a mixed performance on Wednesday as investors balanced a sharp global technology selloff against easing geopolitical concerns in the Middle East. The FTSE 100 managed to stay in positive territory, while Germany’s DAX came under pressure from weakness in technology and semiconductor stocks. Market participants also monitored political developments in the UK…
Segro Rejects £12.6bn Prologis Takeover Approach as US Rival Bid Stalls for FTSE Warehouse Firm
Segro (LSE: SGRO) rejected a £12.6 billion all-share takeover approach from US logistics giant Prologis (NYSE: PLD) on June 23, 2026. The proposal submitted on June 16 offered 0.084 new Prologis shares per Segro share, valuing the FTSE 100 firm at 925p per share, a 24.6% premium to Segro’s closing price of 742p. Prologis went…
Meesho (NSE: MEESHO) Shares Jump 7.3% to ₹184.80 as Citibank Highlights Strategic Edge in E-Commerce Market
Meesho shares gained 7.3% to ₹184.80 on June 23, 2026, after Citibank initiated coverage with a bullish outlook on the company’s future. The move drew strong investor attention and highlighted Meesho’s growing influence in India’s fast-expanding e-commerce market. As online shopping demand continues to rise across smaller cities and towns, analysts see the company benefiting…
Sterling & Wilson Renewable Shares Jump 7.3% to ₹260.80 on Reports of $560 Million Egypt Solar Project Win
Sterling & Wilson Renewable (NSE: SWSOLAR) surged 7.3% to an intraday high of ₹260.80 on June 23, 2026, from a prior close of ₹242.91. The catalyst was a reported $560 million EPC contract win for the West Minya Solar Power Project in Egypt, secured through a joint venture with Hassan Allam Construction. The project is…
FTSE 100 Falls 0.71% as Investors Assess Post-Starmer Political Uncertainty and Burnham Transition
The FTSE 100 moved lower on Tuesday as investors weighed the political impact of Prime Minister Keir Starmer’s resignation and the growing possibility of Andy Burnham taking over the country’s leadership. Market participants also monitored broader European weakness, currency movements, and concerns about future fiscal policy. The decline came after a brief relief rally a…
Bitcoin Drops 1.2% Below $64K Amid Persistent Institutional Selling and Fed Rate Concerns
Bitcoin slipped below the $64,000 mark in late June 2026, extending a period of market uncertainty driven by institutional selling and concerns over U.S. interest rates. The world’s largest cryptocurrency has struggled to regain momentum as investors weigh the impact of Federal Reserve policy and slowing demand from major market participants. With Bitcoin approaching key…
Voltas Ltd (NSE: VOLTAS) Falls 1.87% to ₹1,328.70 as Company Sells 1 Million AC Units in Q1 FY27
Voltas achieved a major milestone in the first quarter of FY27, selling more than 1 million air conditioners in record time. The announcement came in June 2026, highlighting strong demand for cooling products across India despite a competitive market. Yet, the company’s share price slipped 1.87% to ₹1,328.70, raising questions among investors. Why did the…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…